Nelms K, Hromas R, Van Ness B
Institute of Human Genetics, University of Minnesota, Minneapolis 55455.
Nucleic Acids Res. 1990 Feb 25;18(4):1037-43. doi: 10.1093/nar/18.4.1037.
Control of kappa immunoglobulin light-chain gene expression requires the interaction of tissue specific and developmentally regulated DNA-binding proteins with the kappa gene enhancer. Deletion of enhancer sequences upstream from the NF-kB binding site has been shown to impair enhancer function, implying additional proteins may interact with these sequences. In surveying this region for sites of protein binding, a novel DNA-protein interaction, designated kBF-A, was detected. The binding activity of this factor appears to be specific to activated pre-B cells and correlates with high level induction of kappa transcription in these cells.
κ免疫球蛋白轻链基因表达的调控需要组织特异性和发育调控的DNA结合蛋白与κ基因增强子相互作用。已证明删除NF-κB结合位点上游的增强子序列会损害增强子功能,这意味着可能有其他蛋白质与这些序列相互作用。在检测该区域的蛋白质结合位点时,发现了一种新的DNA-蛋白质相互作用,命名为kBF-A。该因子的结合活性似乎对活化的前B细胞具有特异性,并与这些细胞中κ转录的高水平诱导相关。